Clinical Outcome of Extended-depth-of-focus Trifocal Intraocualr Lens (Triumf) Implantation

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04392024

Enrollment

Registered

2020-05-18

Start date

2020-01-29

Completion date

2022-01-26

Last updated

2022-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia

Keywords

Depth and focus

Brief summary

Clinical outcome of extended-depth-of-focus trifocal intraocualr lens (Triumf) implantation

Interventions

DEVICETriumf

Triumf is intraocular lens which offers multifocal vision by extended depth of focus and diffractive optics.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

21 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

1. Adult at the age of 21 or older at the time of the pre-operative examination and willing to have surgery on their 2nd eye within 7-28 days of their 1st eye 2. Age-related cataract 3. A patient with preoperative corneal astigmatism from IOL Master less than 1 diopters 4. A patient want presbyopia correction at the same time as cataract surgery 5. A patient has the visual potential of 20/25 or better in each eye after cataract removal and IOL implantation 6. Written informed consent to surgery and participation in the study

Exclusion criteria

1. Those with other diseases that can affect capsule stability such as pseudoexoliation syndrome, glaucoma, traumatic cataract 2. Pregnant woman and lactating woman 3. A patient with history of ocular trauma or ocular surgery (Intraocular surgery, refractive surgery, ocular surface surgery) in either eye 4. A patient with evidence of keratoconus or significant irregular astigmatism on pre-operative topography in either eye 5. If expectations for presbyopia correction are too high 6. Those who are not able to read and understand the informed consent (illiterate or foreigners)

Design outcomes

Primary

Measure	Time frame	Description
Uncorrected distant visual acuity	3 months	Visual acuity at distant with bare eyes
Uncorrected near visual acuity	3 months	Visual acuity at near with bare eyes

Secondary

Measure	Time frame	Description
Contrast sensitivity	3 months	Ability to recognize figure or letter at different contrast environment
Quality of Vision	3 months	Degree of various symptoms associated with vision

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026